The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer
暂无分享,去创建一个
L. Case | J. Brockschmidt | H. Muss | B. Gregory | T. Kute | L. Kammire | R. Long | L. R. Smith | Cathy Booher
[1] G M Clark,et al. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. , 1989, The New England journal of medicine.
[2] R. Gelber,et al. Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer. , 1987, Cancer research.
[3] Edwin Silverberg,et al. Survival experience in the breast cancer detection demonstration project , 1987, CA: a cancer journal for clinicians.
[4] R. W. Baldwin,et al. Tumour aneuploidy, prognostic parameters and survival in primary breast cancer. , 1987, British Journal of Cancer.
[5] O. Kallioniemi,et al. Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer. , 1987, European journal of cancer & clinical oncology.
[6] S. Fosså,et al. Primary breast cancer: Flow cytometric dna pattern in relation to clinical and histopathologic characteristics , 1986 .
[7] Robert W. McDivitt,et al. A proposed classification of breast cancer based on kinetic information derived from a comparison of risk factors in 168 primary operable breast cancers , 1986, Cancer.
[8] M. Daidone,et al. Cell kinetics as a prognostic marker in node‐negative breast cancer , 1985, Cancer.
[9] L. Skoog,et al. DNA distribution, cytosol estrogen receptors and axillary nodes as prognostic predictors in breast carcinoma. , 1985, Acta radiologica. Oncology.
[10] M. Daidone,et al. Cell kinetics and in vitro chemosensitivity as a tool for improved management of patients. , 1985, European journal of cancer & clinical oncology.
[11] D. Seckinger,et al. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival. , 1984, Cancer research.
[12] J. Meyer,et al. A method for dissociation of viable human breast cancer cells that produces flow cytometric kinetic information similar to that obtained by thymidine labeling. , 1984, Cancer research.
[13] B. Barlogie,et al. Flow cytometry in clinical cancer research. , 1983, Cancer research.
[14] M. M. McCrate,et al. Prediction of early course of breast carcinoma by thymidine labeling , 1983, Cancer.
[15] M. Melamed,et al. Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor , 1981, Cancer.
[16] E. Sugarbaker,et al. Preparation of tissues for DNA flow cytometric analysis. , 1980, Cytometry.
[17] G. Murphy,et al. Management and survival of female breast cancer: Results of a national survey by the American college of surgeons , 1980, Cancer.
[18] J. Meyer,et al. Relationships of S-phase fraction of breast carcinoma in relapse to duration of remission, estrogen receptor content, therapeutic responsiveness, and duration of survival. , 1980, Cancer research.
[19] T. Kute,et al. Improvements in steroid receptor assays including rapid computer analysis of data. , 1980, Analytical biochemistry.
[20] G. Bonadonna,et al. Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients , 1978, Cancer.
[21] C. Haagensen. Treatment of curable carcinoma of the breast. , 1977, International journal of radiation oncology, biology, physics.
[22] J. Fried. Method for the quantitative evaluation of data from flow microfluorometry. , 1976, Computers and biomedical research, an international journal.
[23] B. Fisher,et al. The pathology of invasive breast cancer A Syllabus Derived from Findings of the National Surgical Adjuvant Breast Project (Protocol No. 4) , 1975, Cancer.
[24] I. Ariel,et al. Results of treating 1, 178 patients with breast cancer by radical mastectomy and postoperative irradiation where metastases to axillary lymph nodes occurred , 1979, Journal of surgical oncology.